2013 Summit Tracks

Sessions at the National Rx Drug Abuse Summit are organized into six educational tracks tailored to provide stakeholders timely and relevant information for their particular field. (Updated 1-29-13)
Third-Party Payer  |  Clinical  |  Pharmacy  |  Treatment  |  Education & Advocacy  |  Law Enforcement

Download a 29-page Preview Guide (pdf) to the 2013 National Rx Drug Abuse Summit.

Third-Party Payer

View a description of presentations in this track.

According to the Coalition Against Insurance Fraud (CAIF), drug diversion costs health insurers up to $72.5 billion a year in bogus claims involving opioid abuse alone. Workers dealing with addiction issues, either personally or within their family, become a liability instead of an asset. When this occurs, employers need to be equipped with the knowledge and skills to assist their employees while protecting their own well-being.

These presentations will outline the scope of abuse, detail specific economic and legal impact to employers, provide successful strategies for managing risks, guide human resources staff on workplace support, share strategies to support employees with a suspected addiction, empower employees to become involved in community anti-drug efforts, define what impact third parties can have, and explain steps that can be taken to lower worker’s compensation costs.

Attendees in this track will include insurance providers and payers, human resources executives, economic development officials, local, state, and federal officials, social workers, worker’s compensation officials, and others.
Return to the top


View a description of presentations in this track.

According to the Centers for Disease Control and Prevention (CDC), in the past five years there has been a 345 percent increase in deaths linked to oxycodone. Healthcare providers are often caught in difficult circumstances regarding Rx drug dependency and quality of patient care. Clinically-driven training to identify substance use problems are critically important for curbing this epidemic.

The Clinical Track will provide insight on neonatal abstinence syndrome, risk assessment, prescribing practices, and how to implement changes to lower the cost of pain management.

The Clinical Track is for physicians, physician assistants, nurse practitioners, nurses, hospital administrators, dentists, pharmacists, and others.
Return to the top


View a description of presentations in this track.

According to The Centers for Disease Control and Prevention (CDC), more people die from accidental drug overdoses than car accidents each year in the United States, averaging one death every 15 minutes. Because of this epidemic, pharmacists are often caught in the middle of a patient abusing a prescription from a prescriber.

The Pharmacy track’s focus is to assist pharmacists on their rights and responsibilities to follow correct dispensing protocol, learn how to create a safer environment for the patient and pharmacist, and better understand the latest strategies to reduce diversion.

This track is designed for pharmacists and clinicians with prescribing privileges.
Return to the top


View a description of presentations in this track.

According to the Substance Abuse and Mental Health Services Agency (SAMHSA), of the 21.6 million Americans who needed treatment for drug and alcohol abuse in 2011, only 2.3 million received any kind of specialized treatment. Because of the current state of the economy, access to treatment has become a major obstacle in the fight against Rx drug abuse.

The treatment track will explore how the Affordable Care Act of 2012 can provide treatment options, how to use medicated assisted treatment, how to provide treatment options for juveniles, elderly, and pregnant women, and how to deal with dual diagnosis.

The treatment track is targeted for treatment providers, social workers, drug court executives, criminal justice professionals, clinicians, and nurses.
Return to the top

Education & Advocacy

View a description of presentations in this track.

The National Institute on Drug Abuse (NIDA) estimates that in the U.S. an average of 2,000 teenagers use prescription medication for the first time without a physician’s guidance. This has a very real and lasting impact on families, communities and the education system.

Topics for this track include: community education, prevention programs, local, state, and federal policies, Internet pharmacy laws, signs and symptoms of prescription drug abuse, and drugged driving, among others.

Speakers in this track will include community advocates, educators, volunteers, local, state and federal legislators, and others.
Return to the top

Law Enforcement

View a description of presentations in this track.

According to the Office of National Drug Control Policy (ONDCP), prescription drugs are now the second most abused category of drugs behind marijuana and ahead of cocaine, heroin, methamphetamine and other drugs. Law enforcement officers working narcotics investigations, as well as street patrol, witness the devastation of these drugs every day. They understand how Rx drug abuse is affecting other crimes in record numbers, and need more tools to combat the illicit activity.

Topics for this track will include undercover investigations, prescription drug trends, incarceration versus treatment, community support for law enforcement, and related policy issues.

Speakers in this track will include local, state, and federal law enforcement and criminal justice officials, state and federal prosecutors, policy experts, private investigators, local, state and federal legislators, and others.
Return to the top